PURPOSE: To report initial experience with intracranial vertebral artery (VA) and basilar artery (BA) percutaneous transluminal angioplasty (PTA) and stenting. METHODS: Eleven patients (10 men; mean age 66 years, range 56-75) with intracranial 14 VA and 3 BA stenoses were managed from December 1997 through November 1999. All patients presented with vertebrobasilar ischemia (VBI) despite antiplatelet and anticoagulant therapy. Clinical presentations included visual disturbance (n = 8), dysarthria/dysphasia (n = 5), and vertigo (n = 5). RESULTS: Five patients underwent PTA only of 7 lesions with a mean preprocedural stenosis of 80% (range 50%-90%) that was reduced to 54% (range 30%-70%) after dilation. Six patients received 9 stents, 2 for VA dissections, 3 for tandem lesions, and 1 for a BA lesion. There were no embolic strokes. Patients were followed by clinical evaluation and personal or telephone interviews. Over a mean 18-month follow-up (range 12-35), 8 (73%) patients remained asymptomatic, while 3 (27%) had permanent deficits, 2 related to the procedure and 1 owing to distal disease CONCLUSIONS: Intracranial VA or BA angioplasty and stenting alleviated symptoms in patients with vertebrobasilar ischemia despite best medical management and may prevent stroke.
PURPOSE: To report initial experience with intracranial vertebral artery (VA) and basilar artery (BA) percutaneous transluminal angioplasty (PTA) and stenting. METHODS: Eleven patients (10 men; mean age 66 years, range 56-75) with intracranial 14 VA and 3 BA stenoses were managed from December 1997 through November 1999. All patients presented with vertebrobasilar ischemia (VBI) despite antiplatelet and anticoagulant therapy. Clinical presentations included visual disturbance (n = 8), dysarthria/dysphasia (n = 5), and vertigo (n = 5). RESULTS: Five patients underwent PTA only of 7 lesions with a mean preprocedural stenosis of 80% (range 50%-90%) that was reduced to 54% (range 30%-70%) after dilation. Six patients received 9 stents, 2 for VA dissections, 3 for tandem lesions, and 1 for a BA lesion. There were no embolic strokes. Patients were followed by clinical evaluation and personal or telephone interviews. Over a mean 18-month follow-up (range 12-35), 8 (73%) patients remained asymptomatic, while 3 (27%) had permanent deficits, 2 related to the procedure and 1 owing to distal disease CONCLUSIONS: Intracranial VA or BA angioplasty and stenting alleviated symptoms in patients with vertebrobasilar ischemia despite best medical management and may prevent stroke.
Authors: Michael M Chow; Thomas J Masaryk; Henry H Woo; Marc R Mayberg; Peter A Rasmussen Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: Sepideh Amin-Hanjani; Linda Rose-Finnell; DeJuran Richardson; Sean Ruland; Dilip Pandey; Keith R Thulborn; David S Liebeskind; Gregory J Zipfel; Mitchell S V Elkind; Jeffrey Kramer; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel Journal: Int J Stroke Date: 2010-12 Impact factor: 5.266
Authors: Nso Nso; Mahmoud Nassar; Mia Trimingham; Yolanda Mbome; Anthony Lyonga Ngonge; Solomon O Badejoko; Shahzad Akbar; Atika Azhar; Sofia Lakhdar; Muhammad Ghallab; Laura M Guzman Perez; Vincent Rizzo; Most Sirajum Munira Journal: Cureus Date: 2022-05-05
Authors: Matthew D Alexander; Jeffrey M Rebhun; Steven W Hetts; Matthew R Amans; Fabio Settecase; Robert J Darflinger; Christopher F Dowd; Van V Halbach; Randall T Higashida; Daniel L Cooke Journal: Surg Neurol Int Date: 2017-11-20
Authors: James I Ausman; David S Liebeskind; Nestor Gonzalez; Jeffrey Saver; Neil Martin; J Pablo Villablanca; Paul Vespa; Gary Duckwiler; Reza Jahan; Tianyi Niu; Noriko Salamon; Bryan Yoo; Satoshi Tateshima; Manuel M Buitrago Blanco; Sidney Starkman Journal: Surg Neurol Int Date: 2018-05-24